Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Thailand - Delayed Quote THB

Asian Phytoceuticals Public Company Limited (APCO-R.BK)

Compare
3.2400
+0.0200
+(0.62%)
At close: April 18 at 4:36:21 PM GMT+7
Currency in THB All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
210,830.3840
210,830.3840
292,761.7060
250,381.3780
223,351.5270
Cost of Revenue
40,963.5920
40,963.5920
57,245.1040
47,939.3480
46,263.8020
Gross Profit
169,866.7920
169,866.7920
235,516.6020
202,442.0300
177,087.7250
Operating Expense
116,757.4280
116,757.4280
118,625.8090
114,409.1000
103,267.8710
Operating Income
53,109.3640
53,109.3640
116,890.7930
88,032.9300
73,819.8540
Net Non Operating Interest Income Expense
8,925.9610
8,925.9610
11,661.5440
9,044.5910
6,757.7410
Other Income Expense
5,943.0350
5,943.0350
4,632.4790
3,397.2090
4,912.2560
Pretax Income
67,978.3600
67,978.3600
133,184.8160
100,474.7300
85,489.8510
Tax Provision
12,211.1490
12,211.1490
24,449.6050
19,279.2950
16,790.8090
Net Income Common Stockholders
54,710.8950
54,710.8950
107,491.4290
80,915.7830
68,699.0420
Diluted NI Available to Com Stockholders
54,710.8950
54,710.8950
107,491.4290
80,915.7830
68,699.0420
Basic EPS
0.09
--
0.18
0.13
0.11
Diluted EPS
0.09
--
0.18
0.13
0.11
Basic Average Shares
601,218.6260
--
600,510.7770
599,820.4820
599,991.6330
Diluted Average Shares
601,218.6260
--
600,510.7770
599,820.4820
599,991.6330
Total Operating Income as Reported
53,109.3640
53,109.3640
116,890.7930
88,032.9300
73,819.8540
Total Expenses
157,721.0200
157,721.0200
175,870.9130
162,348.4480
149,531.6730
Net Income from Continuing & Discontinued Operation
54,710.8950
54,710.8950
107,491.4290
80,915.7830
68,699.0420
Normalized Income
51,208.4164
51,208.4164
104,741.8364
78,661.4797
64,522.7774
Interest Income
10,518.7420
10,518.7420
12,322.8210
9,610.8220
7,621.9980
Interest Expense
1,592.7810
1,592.7810
661.2770
566.2310
864.2570
Net Interest Income
8,925.9610
8,925.9610
11,661.5440
9,044.5910
6,757.7410
EBIT
69,571.1410
69,571.1410
133,846.0930
101,040.9610
86,354.1080
EBITDA
90,250.6370
90,250.6370
155,996.7920
124,286.5170
113,311.7530
Reconciled Cost of Revenue
40,963.5920
40,963.5920
57,245.1040
47,939.3480
46,263.8020
Reconciled Depreciation
20,679.4960
20,679.4960
22,150.6990
23,245.5560
26,957.6450
Net Income from Continuing Operation Net Minority Interest
54,710.8950
54,710.8950
107,491.4290
80,915.7830
68,699.0420
Total Unusual Items Excluding Goodwill
4,269.4040
4,269.4040
3,367.8510
2,789.5720
5,196.9900
Total Unusual Items
4,269.4040
4,269.4040
3,367.8510
2,789.5720
5,196.9900
Normalized EBITDA
85,981.2330
85,981.2330
152,628.9410
121,496.9450
108,114.7630
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
766.9254
766.9254
618.2584
535.2687
1,020.7254
12/31/2021 - 4/4/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade